Co Don Gmbh Is A Biopharmaceutical Company Based In Leipziggermanyspecializing In Autologous Cell Therapies For Cartilage Regenerationwith Over 30 Years Of Experienceco Don Focuses On Tissue Engineeringparticularly For Articular Cartilage Defectsthe Company Has Treated More Than 19 000 Patients Globally Since Its First Procedure In 1997 And Emphasizes Personalized Regenerative Medicine That Utilizes Patientsown Cells The Flagship Productspheroxa Is An Eu Approved Cell Therapy Designed For Knee Cartilage Defectsit Employs Autologous Chondrocyte Spheroids To Repair Tissue And Has Received Marketing Authorization In Several Regionsincluding The Euswitzerlandand The Ukco Don Also Operates Large Scale Cell Production Facilities In Leipzig And Is Committed To Research And Developmentparticularly In Minimally Invasive Treatments For Joint Preservationthe Company Aims To Expand Its Market Access Across Europe And Make Personalized Cell Therapies More Accessible To Patients With Articular Cartilage Damage
